Background: The flexible ureterorenoscope (URS) and associated devices have developed rapidly. However, despite its therapeutic benefits, URS may be associated with some complications. To the best of our knowledge, there are no studies discussing the complications of flexURS during the learning curve. Methods: A retrospective review of the records of patients who underwent flexURS from January 2005 to June 2013 was performed. To compare the complications after the introduction of flexURS, patients were divided into four groups based on the surgeon's training experience, that is, based on the number of cases performed by the surgeon. A total of 219 cases underwent flexURS. Groups 1, 2, 3, and 4 included 35, 50, 50, and 84 cases, respectively. The complications were classified using the Clavien system (I-IV). Results: The mean operation time and stone-free rate were significantly different (p < 0.001, p = 0.013, respectively). The total complication rates were 13.6, 10, 8.3, and 3.2%, respectively (p = 0.068). The more the surgeon's experience, the less was the complication rate. Despite our best efforts, the incidence of urosepsis was not reduced (p = 0.902). Conclusions: To reduce severe complications, it is necessary to have performed about 100 cases. Increased surgeon experience tended to decrease the risk of severe complications, but the incidence of urosepsis was not reduced.

1.
Galvin DJ, Pearle MS: The contemporary management of renal and ureteric calculi. BJU Int 2006;98:1283-1288.
2.
Johnson DB, Pearle MS: Complications of ureteroscopy. Urol Clin North Am 2004;31:157-171.
3.
Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213.
4.
Best SL, Nakada SY: Flexible ureteroscopy is effective for proximal ureteral stones in both obese and nonobese patients: a two-year, single-surgeon experience. Urology 2011;77:36-39.
5.
Grasso M, Beaghler M, Bagley DH, Strup S: Actively deflectable, flexible cystoscopes: no longer solely a diagnostic instrument. J Endourol 1993;7:527-530.
6.
Harmon WJ, Sershon PD, Blute ML, Patterson DE, Segura JW: Ureteroscopy: current practice and long-term complications. J Urol 1997;157:28-32.
7.
Preminger GM, Tiselius HG, Assimos DG, et al: 2007 Guideline for the management of ureteral calculi. J Urol 2007;178:2418-2434.
8.
Turna B, Stein RJ, Smaldone MC, et al: Safety and efficacy of flexible ureterorenoscopy and holmium:YAG lithotripsy for intrarenal stones in anticoagulated cases. J Urol 2008;179:1415-1419.
9.
Blew BD, Dagnone AJ, Fazio LM, Pace KT, Honey RJ: Practical comparison of four nitinol stone baskets. J Endourol 2007;21:655-658.
10.
Korman E, Hendlin K, Chotikawanich E, Monga M: Comparison of small diameter stone baskets in an in vitro caliceal and ureteral model. J Endourol 2011;25:123-127.
11.
Ayyathurai R, Kanagarajah P, Shields J, et al: Single-center clinical comparison of two reinforced ureteral access sheaths for retrograde ureteroscopic treatment of urinary lithiasis. Int Urol Nephrol 2012;44:409-414.
12.
Wang HH, Huang L, Routh JC, et al: Use of the ureteral access sheath during ureteroscopy in children. J Urol 2011;186:1728-1733.
13.
Cetti RJ, Biers S, Keoghane SR: The difficult ureter: what is the incidence of pre-stenting? Ann R Coll Surg Engl 2011;93:31-33.
14.
Campbell-Walsh Urology, ed 10. Saunders Elsevier, p 1407.
15.
Kourambas J, Byrne RR, Preminger GM: Does a ureteral access sheath facilitate ureteroscopy? J Urol 2001;165:789-793.
16.
Delvecchio FC, Auge BK, Brizuela RM, et al: Assessment of stricture formation with the ureteral access sheath. Urology 2003;61:518-522.
17.
Rehman J, Monga M, Landman J, et al: Characterization of intrapelvic pressure during ureteropyeloscopy with ureteral access sheaths. Urology 2003;61:713-718.
18.
Auge BK, Pietrow PK, Lallas CD, et al: Ureteral access sheath provides protection against elevated renal pressures during routine flexible ureteroscopic stone manipulation. J Endourol 2004;18:33-36.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.